AB-Free Kava, our exclusive formula, safeguarded by intellectual property rights in key markets, is meticulously crafted with noble kava root known for its calming properties over generations. Manufactured in the USA, our product boasts a transparent list of premium ingredients and is backed by rigorous laboratory testing for quality assurance.

​

AB-Free Kava:

1. Enriches six major kavalactones, which are responsible for kava’s relaxing property (1), demonstrate the potential to prevent cancer (5, 13, 14) and suppress inflammation (15) in pre-clinical animal models

2. Completely removes flavokavains A and B (5), the chemicals likely contributing to the purported hepatotoxic risk associated with kava use in late 1990s.

3. Results in four clinical trials (NCT03843502, NCT04565145, NCT05381025 and NCT05081882) revealed no signs of liver stress at the recommended dose and regimen for AB-Free Kava usage (16, 17)

4. IP protection: Patents granted in USA, China, and Europe

​​​

Flavokavains A and B:

1. Not responsible for kava’s relaxing property nor cancer preventive activity (1-5)

2. The most cytotoxic compounds in kava that kill a wide range of cells (6, 7).

3. Contain a reactive functional group that can trap glutathione,(8) which may compromise liver to hepatotoxic challenges.

4. Induces liver toxicity in pre-clinical animal models alone and enhances the hepatotoxicity of acetaminophen (8, 9).

5. Non-noble kava cultivars (not recommended for human use), such as “Tudei” cultivars, contain 4 times more flavokavains A and B relative to noble kava cultivars (traditionally used for kava drink preparations).(10, 11)

6. “Tudei” kava has been included in the kava product pipeline in Europe when the kava demand was high in the late 1990s, coinciding with the hepatotoxic cases detected among kava users.(12)